Quinlan Paul T 4
4 · CymaBay Therapeutics, Inc. · Filed Mar 15, 2024
Insider Transaction Report
Form 4
Quinlan Paul T
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-03-13$7.89/sh+41,824$329,991→ 70,262 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-03-13−41,824→ 8,872 totalExercise: $7.89Exp: 2030-10-11→ Common Stock (41,824 underlying)
Footnotes (1)
- [F1]The option grant vests as to 1/4 of the underlying shares on October 12, 2021 and as to 1/48 of the underlying shares monthly thereafter.